Efficiency of hepatocyte pretreatment with coenzyme Q₁₀ against statin toxicity

1. Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM. Risks associated with statin therapy: a systematic overview of randomized clinical trials.Circulat ion 2006;114:2788-97. doi: 10.1161/ CIRCULATIONAHA.106.62489010.1161/CIRCULATIONAHA.106.62489017159064Search in Google Scholar

2. Kubota T, Fujisaki K, Itoh Y, Yano T, Sendo T, Oishi R.Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Biochem Pharmacol 2004;67:2175-86. PMID: 1516354910.1016/j.bcp.2004.02.03715163549Search in Google Scholar

3. Abdoli N, Heidari R, Azarmi Y, Eghbal MA. Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J Biochem Mol Toxicol 2013;27:287-94. doi: 10.1002/ jbt.2148510.1002/jbt.2148523761184Search in Google Scholar

4. Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol 2012;56:374-80. doi: 10.1016/j. jhep.2011.07.023Search in Google Scholar

5. Ellesat KS, Tollefsen KE, Asberg A, Thomas KV, Hylland K. Cytotoxicity of atorvastatin and simvastatin on primary rainbow trout (Oncorhynchus mykiss) hepatocytes. Toxicol In Vitro 2010;24:1610-8. doi: 10.1016/j.tiv.2010.06.00610.1016/j.tiv.2010.06.00620600806Search in Google Scholar

6. Potgieter M, Pretorius E, Pepper MS. Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutr Rev 2013;71:180-8. doi: 10.1111/ nure.1201110.1111/nure.1201123452285Search in Google Scholar

7. Deichmann R, Lavie C, Andrews S. Coenzyme Q10 and statin-induced mitochondrial dysfunction. Ochsner J 2010;10:16-21. PMCID: PMC3096178Search in Google Scholar

8. Martin SB, Cenini G, Barone E, Dowling AL, Mancuso C, Butterfield DA, Murphy MP, Head E. Coenzyme Q10 and cognition in atorvastatin treated dogs. Neurosci Lett 2011;501:92-5. doi: 10.1016/j.neulet.2011.06.05410.1016/j.neulet.2011.06.054317409121763754Search in Google Scholar

9. Abadi A, Crane JD, Ogborn D, Hettinga B, Akhtar M, Stokl A, Macneil L, Safdar A, Tarnopolsky M. Supplementation with alpha-lipoic acid, CoQ10, and vitamin E augments running performance and mitochondrial function in female mice. PLoS One 2013;8:e60722.10.1371/journal.pone.0060722361498623565271Search in Google Scholar

10. Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007;99:1409-12. PMID: 1749347010.1016/j.amjcard.2006.12.06317493470Search in Google Scholar

11. Mas E, Mori TA. Coenzyme Q10 and statin myalgia: what is the evidence? Curr Atheroscler Rep 2010;12:407-13. doi: 10.1007/s11883-010-0134-310.1007/s11883-010-0134-320725809Search in Google Scholar

12. Vidyarthi M, Jacob P, Chowdhury TA. Oral use of “Low and Slow” rosuvastatin with co-enzyme Q10 in patients with statin-induced myalgia: retrospective case review. Indian J Endocrinol Metab 2012;16(Suppl 2): S498-500. doi: 10.4103/2230-8210.10414410.4103/2230-8210.104144360312623565478Search in Google Scholar

13. Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, George PM, Scott RS. Effect of coenzyme Q10 supplementation on simvastatin-induced myalgia. Am J Cardiol 2007;100:1400-3. PMID: 1795079710.1016/j.amjcard.2007.06.03017950797Search in Google Scholar

14. Vaughan Ms RA, Garcia-Smith R, Bisoffi M, Conn CA, Trujillo KA. Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur J Pharmacol 2013;711:1-9. doi: 10.1016/j.ejphar.2013.04.00910.1016/j.ejphar.2013.04.00923624330Search in Google Scholar

15. González R, Ferrín G, Hidalgo AB, Ranchal I, López-Cillero P, Santos-Gónzalez M, López-Lluch G, Briceño J, Gómez MA, Poyato A, Villalba JM, Navas P, de la Mata M, Muntané J. N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Chem Biol Interact 2009;181:95-106. doi: 10.1016/j.cbi.2009.06.00310.1016/j.cbi.2009.06.00319523936Search in Google Scholar

16. Moldéus P, Thor H, Högberg J, Orrenius S. Drug metabolism and toxicity studies in isolated rat liver cells. International congress series no. 417. Amsterdam: Excerpta medica; New York: distributed by Elsevier North-Holland; 1977. p. 75-84.Search in Google Scholar

17. Heidari R, Babaei H, Eghbal MA. Cytoprotective effects of taurine against toxicity induced by isoniazid and hydrazine in isolated rat hepatocytes. Arh Hig Rada Toksikol 2013;64:201-9. doi: 10.2478/10004-1254-64-2013-229710.2478/10004-1254-64-2013-229723819928Search in Google Scholar

18. Björkhem-Bergman L, Lindh JD, Bergman P. What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br J Clin Pharmacol 2011;72:164-5. doi: 10.1111/j.1365-2125.2011.03907.x10.1111/j.1365-2125.2011.03907.x314120021223360Search in Google Scholar

19. O’Brien PJ, Chan K, Silber PM. Human and animal hepatocytes in vitro with extrapolation in vivo. Chem Biol Interact 2004;150:97-114. PMID: 1552226410.1016/j.cbi.2004.09.00315522264Search in Google Scholar

20. Delaney S. Accelerated Cytotoxicity Mechanism Screening of 4-Aminobiphenyl in an in vitro Hepatocyte Inflammation Model. [PhD thesis]. Toronto: Graduate Department of Pharmaceutical Sciences, University of Toronto; 2011.Search in Google Scholar

21. Heidari R, Babaei H, Eghbal MA. Amodiaquine-induced toxicity in isolated rat hepatocytes and the cytoprotective effects of taurine and/or N-acetyl cysteine. Res Pharm Sci 2014;9:97-105.Search in Google Scholar

22. Heidari R, Babaei H, Eghbal MA. Ameliorative effects of taurine against methimazole-induced cytotoxicity in isolated rat hepatocytes. Sci Pharm 2012;80:987-99. doi: 10.3797/ scipharm.1205-1610.3797/scipharm.1205-16352805723264945Search in Google Scholar

23. Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nature Protocols 2006;1:3159-65. PMID: 1740657910.1038/nprot.2006.37817406579Search in Google Scholar

24. Heidari R, Babaei H, Eghbal M. Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes. Drug Chem Toxicol 2013;36:403-11. doi: 10.3109/01480545.2012.74927210.3109/01480545.2012.74927223256569Search in Google Scholar

25. Eghbal MA, Pennefather PS, O’Brien PJ. H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology 2004;203:69-76.PMID: 1536358310.1016/j.tox.2004.05.02015363583Search in Google Scholar

26. Benzie IF. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996;47:233-61. PMID: 873577910.3109/09637489609012586Search in Google Scholar

27. Muraki A, Miyashita K, Mitsuishi M, Tamaki M, Tanaka K, Itoh H. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.J Appl Physiol 2012;113:479-86. doi: 10.1152/ japplphysiol.01362.201110.1152/japplphysiol.01362.2011Search in Google Scholar

28. Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A. Adverse effects of statins - mechanisms and consequences. Curr Drug Saf 2009;4:209-28. PMID: 1953464810.2174/157488609789006949Search in Google Scholar

29. La Guardia PG, Alberici LC, Ravagnani FG, Catharino RR, Vercesi AE. Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation. Front Physiol 2013;4:103. doi: 10.3389/fphys.2013.0010310.3389/fphys.2013.00103Search in Google Scholar

30. Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007;7(Suppl):S41-50. PMID: 1748288810.1016/j.mito.2007.02.006Search in Google Scholar

31. Villalba JM, Navarro F, Gómez-Díaz C, Arroyo A, Bello RI, Navas P. Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membrane. Mol Aspects Med 1997;18(Suppl):S7-13. PMID: 926650110.1016/S0098-2997(97)00015-0Search in Google Scholar

32. Moreira PI, Santos MS, Sena C, Nunes E, Seiça R, Oliveira CR. CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp Neurol 2005;196:112-9. doi: 10.1016/j.expneurol.2005.07.01210.1016/j.expneurol.2005.07.01216126199Search in Google Scholar

33. Ali SA, Faddah L, Abdel-Baky A, Bayoumi A. Protective effect of l-carnitine and coenzyme Q10 on CCL4-induced liver injury in rats. Sci Pharm 2010;78:881-96. doi: 10.3797/ scipharm.1006-0210.3797/scipharm.1006-02300761221179323Search in Google Scholar

34. Gebhardt R, Hengstler JG, Müller D, Glöckner R, Buenning P, Laube B, Schmelzer E, Ullrich M, Utesch D, Hewitt N, Ringel M, Hilz BR, Bader A, Langsch A, Koose T, Burger HJ, Maas J, Oesch F. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev 2003;35:145-213. PMID: 12959414 10.1081/DMR-12002368412959414Search in Google Scholar